Login / Signup

SGLT2 inhibitors may offer benefit beyond diabetes.

Amy KangMeg J Jardine
Published in: Nature reviews. Nephrology (2021)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control